CN100425274C - 一种治疗失眠症的中药药物 - Google Patents
一种治疗失眠症的中药药物 Download PDFInfo
- Publication number
- CN100425274C CN100425274C CNB2006101383213A CN200610138321A CN100425274C CN 100425274 C CN100425274 C CN 100425274C CN B2006101383213 A CNB2006101383213 A CN B2006101383213A CN 200610138321 A CN200610138321 A CN 200610138321A CN 100425274 C CN100425274 C CN 100425274C
- Authority
- CN
- China
- Prior art keywords
- insomnia
- chinese medicine
- medicine
- radix
- sleep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 60
- 206010022437 insomnia Diseases 0.000 title claims abstract description 60
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 241000217407 Margaritifera Species 0.000 claims description 4
- 241000244155 Taenia Species 0.000 claims description 4
- 229910000831 Steel Inorganic materials 0.000 claims description 3
- 239000000645 desinfectant Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000010959 steel Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims 1
- 238000011282 treatment Methods 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 17
- 239000000463 material Substances 0.000 abstract 2
- 241000234435 Lilium Species 0.000 abstract 1
- 240000002924 Platycladus orientalis Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 235000009508 confectionery Nutrition 0.000 description 21
- 208000024891 symptom Diseases 0.000 description 16
- 208000002173 dizziness Diseases 0.000 description 14
- 210000002216 heart Anatomy 0.000 description 14
- 235000014347 soups Nutrition 0.000 description 13
- 238000003745 diagnosis Methods 0.000 description 12
- 206010029216 Nervousness Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 230000003203 everyday effect Effects 0.000 description 11
- 238000011084 recovery Methods 0.000 description 10
- 206010033557 Palpitations Diseases 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 8
- 206010003549 asthenia Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 231100000869 headache Toxicity 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 206010022998 Irritability Diseases 0.000 description 7
- 208000007443 Neurasthenia Diseases 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000002936 tranquilizing effect Effects 0.000 description 7
- 208000019901 Anxiety disease Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010016256 fatigue Diseases 0.000 description 6
- 230000036651 mood Effects 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 239000006187 pill Substances 0.000 description 6
- 208000019116 sleep disease Diseases 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 5
- 208000008454 Hyperhidrosis Diseases 0.000 description 5
- 230000036506 anxiety Effects 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 230000001914 calming effect Effects 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 230000002618 waking effect Effects 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010057315 Daydreaming Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 208000020685 sleep-wake disease Diseases 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000031361 Hiccup Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010024264 Lethargy Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 206010029333 Neurosis Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000023513 hiccough Diseases 0.000 description 2
- 230000037315 hyperhidrosis Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000015238 neurotic disease Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000024335 physical disease Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- -1 stable Chemical compound 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000125 Abnormal dreams Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002820 Antisocial behaviour Diseases 0.000 description 1
- 241000195622 Astasia Species 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- UEQUQVLFIPOEMF-UHFFFAOYSA-N Mianserin Chemical compound C1C2=CC=CC=C2N2CCN(C)CC2C2=CC=CC=C21 UEQUQVLFIPOEMF-UHFFFAOYSA-N 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000037328 acute stress Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
- 229960003120 clonazepam Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 229960005426 doxepin Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229960002336 estazolam Drugs 0.000 description 1
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008941 guipiwan Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- QSLMDECMDJKHMQ-GSXCWMCISA-N maprotiline Chemical compound C12=CC=CC=C2[C@@]2(CCCNC)C3=CC=CC=C3[C@@H]1CC2 QSLMDECMDJKHMQ-GSXCWMCISA-N 0.000 description 1
- 229960004090 maprotiline Drugs 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960003955 mianserin Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 229960001454 nitrazepam Drugs 0.000 description 1
- KJONHKAYOJNZEC-UHFFFAOYSA-N nitrazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1 KJONHKAYOJNZEC-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000013515 script Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种治疗失眠症的中药药物,它是由下述重量配比的原料按常规方法制成的汤剂:百合15、枣仁30、五味子20、柏子仁20、茯神15、竹茹15、远志10、丹参30、甘草10、夜交藤20、珍珠母30、磁石15、淫羊藿10。本发明选用纯天然中药原料,各组分符合药政法规定,利用各味中药的综合作用,对失眠症有治愈的功效,无化学甜味剂,对人体无毒无害;本发明味微甘,无苦涩感,服用方便。本发明经多年临床观察选择病例,十天为一个疗程,日服2次,每次50ml,治愈病人近1000例,症状完全消失为有效,有效率为99%。本发明药物可广泛用于临床治疗失眠症。
Description
技术领域
本发明属于中药药物技术领域,具体涉及一种治疗失眠症的中药药物。
背景技术
失眠症是一种持续相当长时间的睡眠的质和/或量令人不满意的状况,常表现为难以入眠、不能入睡、维持睡眠困难、过早或间歇性醒来而引致睡眠不足。所谓失眠症是一种最常见的睡眠紊乱,是指持续较长时间的睡眠障碍。失眠最主要的症状为睡眠不足,还常可伴随许多不适的症状及精神表现,如头晕目眩、心悸气短、体倦乏力、不思饮食、自汗盗汗、耳鸣耳聋、终日惕惕、胆怯恐惧、急躁易怒、胸胁胀满、恶心口苦、腰酸腿软、注意力不集中、健忘、工作学习效率下降,乃甚至失去工作和学习的能力。严重的失眠还会诱发一些心身性疾病,如出现消瘦、心动过速、腹泻、便秘、血压升高、消化道溃疡病、抑郁症、焦虑症、阳痿、性欲减退等,甚至可引起自杀的行为。随着社会的发展,生活节奏的加快,失眠症的发生率有上升趋势。据统计,约有30%的成人患有失眠。造成失眠的因素较为复杂,有的由心理因素诱发,有的由躯体疾病引起(如甲状腺功能亢进、肺结核,心脏病),而年龄、生活习惯、环境等因素,也与失眠有着密切的关系。专家认为,失眠大多数是由心理因素引起的。工作中的压力、人与人之间的竞争和各种矛盾,以及家庭中的不和谐等等,常常难以应付,从而使人们的精神处在一种高度紧张的状态。这种紧张状态使得睡眠时情绪无法平静,心神不安,失眠随之而来。不少失眠者是由于对睡眠的错误观念引起。他们认为每晚必须睡8小时,当自己睡不足此量时,便产生疑虑,担心睡眠不够。人们在日常生活中,会经常遇到急性应激事件,如工作出现麻烦,亲人亡故等等。这会使人过度兴奋,引起睡眠障碍。大多数人随着事件的解决,睡眠马上恢复正常。可一些人对这种偶尔的睡眠障碍顾虑重重,怀疑是严重的失眠症或神经衰弱之类的疾病。这样,原来的心理应激平复后,对失眠的焦虑反而成了主要的心理紧张压力。患者每晚提心吊胆地怀着惧怕失眠的心情就寝,结果越是紧张焦虑,越是难以入睡,刚要睡着,又自行惊醒,即使入睡后,睡眠质量也较差。如果这时医生给用安眠药,就有可能使此人经常需要求助于安眠药,甚至发展成为失眠症患者。目前,临床对失眠症的治疗主要以口服抗焦虑、镇静、催眠药物,如:米安色林、阿米替林、多塞平、马普替林、安定,氯硝安定及佳乐安定等。安眠药只适用于急性心理应激和躯体疾病引起的暂时性失眠,或者用于重症精神病的睡眠障碍。对于通常的失眠症患者来说,安眠药是弊多利少。通过对应用安眠药引起药物性睡眠的脑电图研究证明,西药睡眠不同于生理睡眠,其中最突出的是积极睡眠的比例显著减少。服药后虽然整夜入睡,但积极睡眠严重不足,因而早晨醒来仍然昏昏沉沉,好像没睡一样。这会使失眠症变得更加复杂。而且,长期使用安眠药、会使机体产生耐药性,即药物的作用越来越低;同时扰乱了脑组织的正常物质代谢,以致产生药物依赖性,也即通常所说的药物成瘾。祖国医学对失眠的论述颇多。中医认为,失眠即“不寐”,亦称“不得眠”、“不得卧”、“目不瞑”等,是因为外感或内伤等病因,致使心、肝、胆、脾、胃、肾等脏腑功能失调,心神不安,以致经常不得入寐的一种病证。正如《伤寒六书》中说:“阳盛阴虚,则昼夜不得眠,盖夜以阴为主,阴气盛则目闭而卧安;若阴为阳所胜,故终夜烦扰而不得眠也”。失眠在《内经》中称之为“目不瞑”、“不得眠”、“不得卧”;《难经》始称“不寐”;《中藏经》称“无眠”;《外台秘要》称“失眠”;《圣济总录》称“少睡”;《太平惠民和剂局方》则称“少寐”;《杂病广要》称之谓“不睡”。
总之,脏腑功能紊乱、邪气阻滞、气血阴阳平衡失调、神志不宁是发生失眠的基本病机。目前的中成药主要有安神健脑片、柏子养心丸、归脾丸等。但其生产成本高、制造工艺复杂。
发明内容
发明的目的是提供一种标本兼治、无副作用、价格低廉、加工简单的治疗失眠症的中药药物,以克服现有技术的不足。
本发明的解决方案是基于祖国医学对失眠症的发病机理和提高机体免疫力的认识及治疗原则,参考古、今药理研究成就,从祖国医学宝库中,筛选出疏肝解郁、理气化痰,疏肝解郁、活血通络,滋阴潜阳、重镇安神,健脾益气、养心安神的天然中药,按中医理论组方,提取精华,使其发挥促进人体内气血阴阳及五脏六腑十二经络平衡、稳定情绪、安神健脑,对失眠症有治愈和抑制的功效。
本发明药物是由下列组分制成的(用量为重量份):
百合15、枣仁30、五味子20、柏子仁20、茯神15、竹茹15、远志10、丹参30、甘草10、夜交藤20、珍珠母30、磁石15、淫羊藿10
将上述各组分按常规方法制成中药汤剂,依次按下述步骤完成:
1)煎煮:将上述诸药放入砂锅或不锈钢高压锅内,按药物总量的1∶2加水文火煎煮,沸后20分钟,将药液滤出,再按药物总量的1∶1加水文火煎煮,沸后20分钟,将药液滤出;
2)装瓶:将两次滤液混匀后装入事先已消毒的瓶子内密封;
3)消毒:将药液瓶放入高压锅内杀菌20分钟,即得本发明中药药物汤剂。
本发明中药药物汤剂定名为:“甜梦汤”。
本发明药物中的百合,性寒、味苦,功能主治:阴润肺、清心安神,用于阴虚久咳、痰中带血、虚烦惊悸、失眠多梦、精神恍惚;枣仁,性平、味甘、酸,归心、肝经,功能主治:养心、安神、敛汗,用于神经衰弱、失眠、多梦、盗汗;五味子,味酸、温,入肝、心经,具有敛肺滋肾、生津敛汗、涩精止血、宁心安神之功效,主治肺虚久咳、肺肾虚咳、自汗、盗汗、消渴、梦遗、滑精、久泻不止、心悸、失眠;柏子仁,味甘、平,入心、肝、脾经,具有养心安神、润肠通便之功效,主治惊悸、失眠、遗精、盗汗、便秘;茯神,药性平、味甘、淡,具有宁心、安神、利水之功效,主治心虚惊悸、健忘、失眠、惊痫、小便不利;竹茹,具有清热、凉血、化痰、止吐、和胃、降逆、除烦之功效,主治烦热呕吐、呃逆、痰热咳喘、吐血、衄血、崩漏、恶阻、胎动、惊癎,味甘辛、性微寒、无毒,入胆、胃、膀胱、脾、肺、心经;远志,具有安神益智、祛痰、解郁、交通心肾,主治惊悸、健忘、梦遗、失眠、咳嗽多痰、痈疽疮肿、郁症,味酸微辛、性平,入心、肝、脾三经;丹参,具有活血祛瘀、安神宁心、排脓、止痛之功效,主治心绞痛、月经不调、痛经、经闭、血崩带下、症瘕、积聚、瘀血腹痛、骨节疼痛、惊悸不眠、恶疮肿毒,味苦、平、微温,入手足少阴、足厥阴经;甘草,性味甘、平,归心、肺、脾、胃经,功能与主治:补脾益气、清热解毒、祛痰止咳、缓急止痛、调和诸药,用于脾胃虚弱、倦怠乏力、心悸气短、咳嗽痰多、脘腹、四肢挛急疼痛、痈肿疮毒、缓解药物毒性、烈性;夜交藤,具有养心、安神、通络、祛风之功效,主治失眠症、劳伤、多汗、血虚身痛、痈疽、瘰疬、风疮疥癣,味甘微苦、平;珍珠母,具有平肝、潜阳、定惊、止血之功效,主治头眩、耳鸣、心悸、失眠、癫狂、惊痫、吐血、衄血、妇女血崩,性味归经:甘成、冷、无毒,入心、肝两经;磁石,具有潜阳纳气、镇惊安神之功效,主治头目眩晕、耳鸣耳聋、虚喘、惊痫、怔忡,味辛、寒,入足少阴肾经、手太阴肺经;淫羊藿,具有补肾阳、强筋骨、祛风湿的功效,用于阳萎遗精、筋骨痿软、风湿痹痛、麻木拘挛、更年期高血压症等。上述诸药经合理配伍对失眠症有特效。
本发明药物汤剂“甜梦汤”临床使用结果表明,有下述优点:
1、本发明选用纯天然中药原料,各组分符合药政法规定,利用各味中药的综合作用,对失眠症有治愈的功效,无化学甜味剂,对人体无毒无害。
2、本发明味微甘,无苦涩感,服用方便。
为表明本发明中药药物汤剂“甜梦汤”的疗效,本发明经多年临床观察选择病例,十天为一个疗程,日服2次,每次50ml,治愈病人近1000例,症状完全消失为有效,有效率为99%。
典型病例如下:
1、刘某,男性,30岁,教师,已婚,大专,因失眠多梦,精神萎靡,容易疲劳来院就诊。患者3年多来,由于工作紧张,任务重,心理压力大,逐渐出现失眠,表现为入睡困难,需二三个小时才能入睡,睡后容易惊醒,多梦。白天昏昏欲睡,精神萎靡,易疲劳,病人往往控制不住,好回忆家务琐事,感觉方面也变得很敏感,常怕光、怕声,有时甚至怕冷、怕热,一点刺激都难以忍受。上课时又会感到脑力不够用,头昏脑胀,打不起精神,注意力不集中或不能持久集中,记忆力下降,甚至浑身疲乏,体力不支,教学成绩下降,并且出现头昏头痛,烦躁易怒。患者曾自服安定类药,病情时轻时重,遂今日来我院诊治。我们让其服用“甜梦汤”,每日两次,2个疗程后症状开始缓解,2月后彻底痊愈,至今未再复发。
2、陈某某,男性,36岁,工人,已婚,由于工作压力近六年来经常感到身体乏力、背部沉重、失眠健忘、精神紧张,每天下班,如同散架,劳累、气短、懒于说话。在睡眠方面,患者多入睡困难,或睡眠浅而多噩梦,易惊醒,醒后难以再入睡,甚至患者自己觉得″不会睡觉″了,而白天患者却无精打采,不住打瞌睡。患者多次去当地医院检查,各项检查指标均为正常,诊断为神经症,采用中药针灸等多种方法治疗,病情总不见好转,为此常对家人发脾气,烦躁易怒,后辗转来我院诊治。诊断为失眠症,服用“甜梦汤”,每日两次,1个疗程后症状开始缓解,1月后彻底痊愈,至今未再复发。
3、王女士,女性,46岁,教师,患者近3年来失眠,特别是入睡困难,伴有头痛、头昏、耳鸣、记忆力减退、困倦无力。有时患者心慌、胸闷、站立不稳、眼前发黑,持续七八分钟才能缓解。患者常感到一天到晚精神疲乏,工作时不自觉地走神,读书看报时注意力难以集中,头晕脑胀,心烦意乱,常为一些小事与家人吵闹不休。患者常因头痛、头晕、心慌、失眠、多汗、纳差、食欲不振、月经不调等,往返于各大医院求治,但经过医生的仔细检查后,总是检查不出相应的可解释的原因。对此患者疑惑不解,忧心重重,怀疑自己患了不治之症,进而责怪医生不负责任,医术不行。遂转来我院诊治。诊断为失眠症,服用“甜梦汤”,每日两次,2个疗程后症状开始缓解,3月后彻底痊愈,至今未再复发。
4、高某,男性,28岁,经商,近5年来由于经营压力整天忙于买卖活动,费心劳神,生活失去了规律,精神紧张引起失眠,后来逐渐发展到头痛、易怒、整天昏昏沉沉、食欲下降,体重减轻,病人总感到心情紧张,放松不下来,而且特别容易烦恼、激动或发脾气,有时甚至出现轻度焦虑、忧愁、自责或敏感多疑,另外,病人往往还会出现肌肉紧张性疼痛,比如稍一紧张就头痛或说不清的肌肉疼痛,有时还伴有心慌、出汗、食欲不佳、消化不良。病人心情烦躁时打骂家人,后来经人介绍来我院诊治,经应用镇静催眠药病情部分缓解,后自行停药病情有明显加重遂再次来诊。服用“甜梦汤”,每日两次,2个疗程后症状开始缓解,2月后彻底痊愈,至今未再复发。
5、刘某某,男性,22岁。学生,未婚,高中。3年前高考时由于学习压力过大用脑过度经常出现头昏、头沉、精力不能集中、入睡困难、易醒、醒后不能再睡、心烦、易怒、胸闷、气短、四肢酸软、五心烦热、胃胀发凉。在某大医院诊断为神经衰弱,取服刺五加、舒乐安定、谷维素、维生素B1等药物治疗病情不见好转。后来出现郁郁寡欢,怀疑自己患了重症,常向家里人诉说“总是好忘事,干家务事丢三拉四,心烦意乱,情绪不好,担心以后还能不能工作。”为进一步诊治遂来我院,诊断为失眠症,服用“甜梦汤”,每日两次,1个疗程后症状开始缓解,2月后彻底痊愈,至今未再复发。
6、孙某某,男性,34岁,农民,已婚,初中,近8年来由于家庭纠纷,生气后失眠,生活失去了规律,心情长期紧张,失眠多为入睡困难、容易惊醒,醒后难以入眠,伴有头痛头昏,困倦无力,白天易疲倦,昏昏沉沉、食欲下降。后来逐渐发展到烦恼、易怒,容易激动或发脾气,体重明显减轻,有时甚至出现轻度忧愁自责或敏感多疑,病人往往怀疑自己患上了心脏病和胃溃疡,自述心慌、出汗、食欲不佳、消化不良。其家人不理解时病人心情愈加烦躁,甚至冲动毁物,后经人介绍曾来我院门诊诊断为神经衰弱失眠症,予改善睡眠、缓解焦虑抑郁,病情缓解,为求进一步诊治遂来我院住院治疗。服用“甜梦汤”,每日两次,1个疗程后症状开始缓解,2月后彻底痊愈,至今未再复发。
7、李某某,女性,52岁,农民,已婚,文盲。近23年来病人终日感到头痛、头昏、周身乏力,全身不固定部位疼痛,有时心慌、气急、便秘、食欲不振、多梦易醒,早晨4点钟左右就醒来,难以再入眠,而白天则感到昏昏沉沉,做事总打不起精神,勉强能做点儿家务事,多次到当地医院心内科、神经科诊治,做过心电图、脑电图、B超、CT等各项检查,报告结果都为正常,诊断都说是神经官能症,服过西药、中药以及针灸治疗,自己也购买过保健品,病情迁延不愈,遂转来我院诊治。诊断为失眠症,服用“甜梦汤”,每日两次,2个疗程后症状开始缓解,3月后彻底痊愈,至今未再复发。
8、张某,男性,45岁,农民,已婚,初中,近15年来患者自感疲劳,力不从心,眼花耳鸣,反应迟钝,记忆力减退。近3月来事多劳累,食欲不振,夜寐欠佳。患者为此过分地紧张担心,总睡不着觉,经常多疑自问“脑子会不会变坏了?”“记忆力下降,自己会不会变傻了?”患者到处求医问药治疗,又总认为病情没治,心情不堪重负,致精神进一步紧张和身体愈加疲劳。遂来我院诊治,门诊以神经衰弱导致失眠收治入院。服用“甜梦汤”,每日两次,2个疗程后症状开始缓解,3月后彻底痊愈,至今未再复发。
9、张某某,男性,40岁,教师,已婚,大学,近8年来失眠、头痛、烦躁、情绪波动大一直缠绕在身。在当地医院被诊断为“神经衰弱”,按照医生嘱咐,患者一直坚持服用硝基安定、佳乐啶药,但病情起起伏伏,“神经衰弱”就像梦魇去而复返。平时病人特别敏感十分注重自身的躯体不适,时说四肢肌肉痛疼无力,有时诉说心慌、出汗,食欲不佳、消化不良。为此往往表现情绪不稳、失眠、郁郁寡欢,对声音也极度敏感,即使轻微的声音也会使其惊恐得心跳、冒汗,遂来我院诊治。服用“甜梦汤”,每日两次,2个疗程后症状开始缓解,2月后彻底痊愈,至今未再复发。
10、李某某,女性,36岁,农民,离婚,初中,10年前因故离婚后经常感到头昏、胸闷、乏力、入睡困难,整天感到昏昏沉沉的,提不起精神,曾到当地市级某医院内科、神经科诊治,各项检查均正常。诊断为“神经衰弱”,服用过好些营养神经补脑药、维生素等。曾经先后花去了上千元,疗效甚微,为此患者苦不堪言。后来经常出现头痛、头晕、失眠、多梦等症状,苦说“心情实在糟透了,原来每夜能睡四五个小时,现在连三个小时都睡不上了,而且夜惊、失眠多梦、晚上半夜睡着,下半夜两、三点种就醒了,再也睡不着,起床后来回走动就盼着天明。”“也经常搅得家里人睡不好觉,心里很郁闷烦躁。”为求进一步诊治遂来我院住院治疗。服用“甜梦汤”,每日两次,1个疗程后症状开始缓解,2月后彻底痊愈,至今未再复发。
具体实施方式
按下述配比称取原料(克):
百合15、枣仁30、五味子20、柏子仁20、茯神15、竹茹15、远志10、丹参30、甘草10、夜交藤20、珍珠母30、磁石15、淫羊藿10;
将上述各组分按常规方法制成中药汤剂,依次按下述步骤完成:
1)煎煮:将上述诸药放入砂锅或不锈钢高压锅内,按药物总量的1∶2加水文火煎煮,沸后20分钟,将药液滤出,再按药物总量的1∶1加水文火煎煮,沸后20分钟,将药液滤出;
2)装瓶:将两次滤液混匀后装入事先已消毒的瓶子内密封;
3)消毒:将药液瓶放入高压锅内杀菌20分钟,即得本发明中药药物汤剂。
Claims (1)
1、一种治疗失眠症的中药药物,其特征在于它是由下述重量配比的药材原料制成的汤剂:百合15、枣仁30、五味子20、柏子仁20、茯神15、竹茹15、远志10、丹参30、甘草10、夜交藤20、珍珠母30、磁石15、淫羊藿10;其制备方法是依次按下述步骤完成的:1)煎煮:将上述诸药放入砂锅或不锈钢高压锅内,按药材原料总量的1∶2加水文火煎煮,沸后20分钟,将药液滤出,再按药材原料总量的1∶1加水文火煎煮,沸后20分钟,将药液滤出;2)装瓶:将两次滤液混匀后装入事先已消毒的瓶子内密封;3)消毒:将药液瓶放入高压锅内杀菌20分钟,即得本发明中药药物汤剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101383213A CN100425274C (zh) | 2006-11-07 | 2006-11-07 | 一种治疗失眠症的中药药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101383213A CN100425274C (zh) | 2006-11-07 | 2006-11-07 | 一种治疗失眠症的中药药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1973889A CN1973889A (zh) | 2007-06-06 |
CN100425274C true CN100425274C (zh) | 2008-10-15 |
Family
ID=38124423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101383213A Expired - Fee Related CN100425274C (zh) | 2006-11-07 | 2006-11-07 | 一种治疗失眠症的中药药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100425274C (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181382B (zh) * | 2007-12-05 | 2010-11-10 | 姜莉蔚 | 一种安神改善睡眠中药贴膏 |
CN101485796B (zh) * | 2008-01-14 | 2013-05-29 | 北京亚东生物制药有限公司 | 治疗失眠的中药组合物及其制备方法 |
US7968128B2 (en) | 2008-11-03 | 2011-06-28 | Viva Pharmaceutical Inc. | Plant extract compositions for affecting sleep |
CN101856401B (zh) * | 2010-06-22 | 2011-09-21 | 马春 | 治疗失眠的外用中药组合物 |
CN102327464B (zh) * | 2011-10-10 | 2013-05-15 | 魏绍良 | 一种治疗失眠的药物 |
CN102784298B (zh) * | 2012-08-01 | 2013-11-13 | 李绍波 | 一种治疗嗜食芥末型失眠的中药制备方法 |
CN102784373B (zh) * | 2012-08-01 | 2013-08-28 | 张勇 | 一种治疗营养不良型失眠的中药制备方法 |
CN102813820B (zh) * | 2012-08-01 | 2013-09-11 | 潘淑先 | 一种治疗心肾不交型失眠的中药制备方法 |
CN103550495B (zh) * | 2013-10-26 | 2015-11-18 | 赵岩 | 一种治疗失眠的中药组合物 |
CN104666981A (zh) * | 2013-12-02 | 2015-06-03 | 青岛永通电梯工程有限公司 | 一种治疗失眠的中药制剂 |
CN104352502A (zh) * | 2014-11-14 | 2015-02-18 | 滑宏巨 | 药物小剂量米安色林在治疗失眠药物中的应用 |
CN107753628B (zh) * | 2016-08-23 | 2021-03-05 | 江苏康缘药业股份有限公司 | 一种治疗失眠的中药组合物及制备方法 |
CN106421652A (zh) * | 2016-10-27 | 2017-02-22 | 何本科 | 一种改善睡眠的中药制剂及其制备方法 |
CN115350254A (zh) * | 2022-09-20 | 2022-11-18 | 河北菲诺健康管理有限公司 | 助眠代茶饮 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513516A (zh) * | 2003-07-24 | 2004-07-21 | 贵州益兴宝典生物科技股份有限公司 | 一种改善睡眠的纯天然保健品及其制法 |
CN1706436A (zh) * | 2005-05-27 | 2005-12-14 | 何文茜 | 一种安神助眠的中成药 |
-
2006
- 2006-11-07 CN CNB2006101383213A patent/CN100425274C/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513516A (zh) * | 2003-07-24 | 2004-07-21 | 贵州益兴宝典生物科技股份有限公司 | 一种改善睡眠的纯天然保健品及其制法 |
CN1706436A (zh) * | 2005-05-27 | 2005-12-14 | 何文茜 | 一种安神助眠的中成药 |
Non-Patent Citations (4)
Title |
---|
不寐的中医药研究概况. 刘顺益.福建中医学院学报,第15卷第2期. 2005 |
不寐的中医药研究概况. 刘顺益.福建中医学院学报,第15卷第2期. 2005 * |
安神十法治失眠. 朱德贵.四川中医,第19卷第7期. 2001 |
安神十法治失眠. 朱德贵.四川中医,第19卷第7期. 2001 * |
Also Published As
Publication number | Publication date |
---|---|
CN1973889A (zh) | 2007-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100425274C (zh) | 一种治疗失眠症的中药药物 | |
CN101912559B (zh) | 一种补肾壮阳、养颜及治疗不孕不育的中药丸 | |
CN102526474B (zh) | 一种治疗神经衰弱的中药组合物 | |
CN102908587A (zh) | 健脑益智丸治疗脑衰竭性精神病 | |
CN102755592B (zh) | 一种治疗精神分裂症的中药制剂 | |
CN104096176A (zh) | 一种治疗焦虑症的中药及制备方法 | |
CN103784878B (zh) | 一种治疗精神病的中药‑镇惊安神丸、汤及其制备方法 | |
CN106214964A (zh) | 安神的中药制剂 | |
CN100571766C (zh) | 一种治疗酒精依赖性疾病的中药药物 | |
CN101810787B (zh) | 一种治疗心烦的中药组合物及其制备方法 | |
CN105999049A (zh) | 一种治疗慢性肾衰竭及其引发症的中药组合物 | |
CN102423407A (zh) | 一种用于调理亚健康状态的中药组合物 | |
CN1292792C (zh) | 一种治疗抑郁症的中药药物 | |
CN103251796A (zh) | 一种治疗失眠的中药 | |
CN105434679A (zh) | 一种用于减肥瘦身的中药保健制剂 | |
CN101773652B (zh) | 一种治疗健忘的中药组合物及其制备方法 | |
CN101564495B (zh) | 精神病阴性四步疗法的初发期症状治疗药物 | |
CN104383421A (zh) | 用于失眠多梦的药物制剂 | |
CN104383420A (zh) | 制备治疗失眠多梦药物制剂的方法 | |
CN103330912B (zh) | 一种治疗失眠症的中药 | |
CN104524188A (zh) | 一种治疗血管性痴呆的药物及其制备方法 | |
CN103989936B (zh) | 一种亚健康调理液及其制备方法 | |
CN106071733A (zh) | 一种安神保健食品 | |
CN103961578A (zh) | 一种治疗神经衰弱的中药药酒 | |
CN104758579A (zh) | 一种治疗肝肾阴虚型更年期综合症的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081015 Termination date: 20091207 |